Literature DB >> 2476142

'Fetal-type' B and T lymphocytes in rheumatoid arthritis and primary Sjögren's syndrome.

C Plater-Zyberk1, F M Brennan, M Feldmann, R N Maini.   

Abstract

B lymphocytes expressing CD5 (CD5+B cells) and T lymphocytes using the gamma and delta chains to form their antigen receptor (gamma delta +T cells) are major populations in developing fetuses, but become relatively minor in normal adults. However, both subsets are expanded in the peripheral blood of more than 50% of patients with rheumatoid arthritis and primary Sjögren's syndrome. We have examined the surface phenotype of these subsets using flow cytometry and have studied the frequency of IgM-producing lines after EBV-transformation of sorted CD5+B and CD5-B cells isolated from neonatal umbilical vein and RA peripheral blood. The intensity of CD5 expression on B cells was at least 10 times 'duller' than on T cells, CD5 'dull' cells were CD3 negative, and T cells bearing the gamma delta antigen receptor did not express either CD4 or CD8 on their surface. In vitro stimulation by Staphylococcus aureus Cowan I or transformation by Epstein-Barr virus of CD5+B cells resulted in loss of CD5 antigen from the surface of B cells. EBV-transformation of sorted CD5+B and CD5-B lymphocytes from neonatal blood gave rise to IgM-secretion in 100% of the Ig-secreting lines. CD5+B fraction isolated from RA blood also generated 100% IgM-secreting lines, whereas 29% of the Ig-secreting lines obtained from RA CD5-B fraction did not secrete IgM. The function of these 'fetal-type' T and B lymphocytes is unknown, however their expansion in rheumatoid arthritis and primary Sjögren's Syndrome suggests that they may play a role in autoimmune diseases.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2476142     DOI: 10.1016/0896-8411(89)90135-2

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  5 in total

1.  CD5 expression by B lymphocytes and its regulation upon Epstein-Barr virus transformation.

Authors:  D Kaplan; D Smith; H Meyerson; N Pecora; K Lewandowska
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-13       Impact factor: 11.205

2.  Lack of natural antibodies in rheumatic diseases.

Authors:  J W Bijlsma; C Plater-Zyberk; P Mumford; R N Maini
Journal:  Rheumatol Int       Date:  1990       Impact factor: 2.631

3.  CD5 (Ly-1)-negative, conventional splenic B cells make a substantial contribution to the bromelain plaque-forming cell response in CBA and BW mice.

Authors:  E M Andrew; W Annis; M Kahan; R N Maini
Journal:  Immunology       Date:  1990-04       Impact factor: 7.397

4.  Autoreactive B-1 B cells: constraints on natural autoantibody B cell antigen receptors.

Authors:  Ben Rowley; Lingjuan Tang; Susan Shinton; Kyoko Hayakawa; Richard R Hardy
Journal:  J Autoimmun       Date:  2007-09-21       Impact factor: 7.094

Review 5.  Abnormalities of B cell phenotype, immunoglobulin gene expression and the emergence of autoimmunity in Sjögren's syndrome.

Authors:  Thomas Dörner; Peter E Lipsky
Journal:  Arthritis Res       Date:  2002-09-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.